ICON Public Limited Company (ICLR)

Market Cap	12.28B
Revenue (ttm)	8.09B
Net Income (ttm)	794.25M
Shares Out	77.77M
EPS (ttm)	9.73
PE Ratio	16.22
Forward PE	11.48
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,205,617
Open	156.81
Previous Close	155.42
Day's Range	155.37 - 159.76
52-Week Range	125.10 - 328.35
Beta	1.17
Analysts	Buy
Price Target	211.92 (+34.25%)
Earnings Date	Jul 23, 2025

About SATX

ICON Public Limited Company, a clinical research organization, provides outsourced development and commercialization services in Ireland, rest of Europe, the United States, and internationally. The company specializes in the strategic development, management, and analysis of programs that support various stages of the clinical development process from compound selection to Phase I-IV clinical studies. It also provides clinical development services, including all phases of development, peri and post approval, data solutions, and site and patient...

• Industry: Diagnostics & Research
• Sector: Healthcare
• IPO Date: May 15, 1998
• Employees: 41,900
• Stock Exchange: NASDAQ
• Ticker Symbol: ICLR
• Website: https://www.iconplc.com

Financial Performance

In 2024, ICLR's revenue was $8.28 billion, an increase of 1.99% compared to the previous year's $8.12 billion. Earnings were $791.47 million, an increase of 29.26%.

Analyst Summary

According to 13 analysts, the average rating for ICLR stock is "Buy." The 12-month stock price target is $211.92, which is an increase of 34.25% from the latest price.

Price Target

$211.92

(34.25% upside)

Analyst Consensus: Buy